RADICALS-HD, a randomised controlled trial in prostate cancer

Findings from the RADICALS-HD study confirm that adding two years, compared to six months, of hormone therapy delays prostate cancer spread in people who had surgery to remove the prostate followed by radiotherapy.
The RADICALS-HD trial was funded by the MRC and Cancer Research UK and took place in hospitals throughout the UK, as well as Canada, Denmark and Ireland.